A-share Selected Announcement | Ningbo Joyson Electronic Corp. (600699.SH) wins a 15 billion yuan automotive intelligent product mega order.
Borui Pharmaceuticals (688166.SH): BGM0504 tablets approved for clinical trials in adults with overweight/obesity. There is currently no similar target oral formulation approved for marketing globally.
1. Today's Focus
1. Ningbo Joyson Electronic Corp.: Subsidiary newly awarded a total of approximately 15 billion yuan for a global automotive intelligence project, scheduled to start mass production from 2027.
Ningbo Joyson Electronic Corp. announced that its subsidiary recently received two notifications of project awards from leading brand OEM customers. The company will develop and provide a range of automotive intelligence products for these customers globally, including CCU, intelligent networking products, etc. According to the customer's plan, the total order amount for the above projects is expected to be approximately 15 billion yuan throughout its lifecycle, scheduled to start mass production from 2027. The awarded projects are not expected to have a significant impact on the company's operating performance this year, but will contribute to increasing the company's future business revenue.
2. Brightgene Bio-Medical Technology Co., Ltd.: BGM0504 tablets approved for clinical trials in overweight/obese adults, the world's first similar target oral formulation not yet approved for market
Brightgene Bio-Medical Technology Co., Ltd. announced that its wholly-owned subsidiary, Borui Pharmaceutical, recently received the Drug Clinical Trial Approval Notice from the National Medical Products Administration, allowing the BGM0504 tablets to undergo clinical trials in overweight/obese adults. BGM0504 is a GLP-1 and GIP receptor dual agonist developed independently by the company, which can stimulate the downstream pathways of GIP and GLP-1, producing biological effects such as blood sugar control, weight loss, and treatment of non-alcoholic fatty liver disease (NASH). The injection of the BGM0504 is currently in Phase III clinical trials for type 2 diabetes and weight loss indications. The BGM0504 tablet is the oral formulation of BGM0504. As of the date of this announcement, there is currently no similar target oral formulation approved for market globally.
3. Amlogic: Plans to acquire 100% equity of Chip Macro Microchip for 316 million yuan
Amlogic announced that it plans to acquire 100% equity of Chip Macro Microchip (Jiaxing) Co., Ltd. in cash, with a total consideration of 316 million yuan. After the completion of the transaction, Chip Macro Microchip will become a wholly-owned subsidiary of the company and will be included in the company's consolidated financial statements. The target company has rich technical accumulation and complete products and solutions in the Internet of Things, vehicle networking, and mobile smart terminal fields. Through this transaction, the company will help to build a multi-dimensional communication technology stack and product matrix of "cellular communication + optical communication + Wi-Fi," ultimately forming a unique competitive AIoT solution focused on "edge intelligence + computing power + communication" supported by hardware and software integrated, catering to multiple scenarios.
4. Dongguan Dingtong Precision Metal Co., Ltd.: Plans to establish a wholly-owned subsidiary in Vietnam for 15 million US dollars, researching, developing, and manufacturing products such as light module liquid cooling radiators
Dongguan Dingtong Precision Metal Co., Ltd. announced that it plans to invest no more than 15 million US dollars to establish a wholly-owned subsidiary in Vietnam for researching, developing, and selling high-speed communication connectors, new energy vehicle connectors, light module liquid cooling radiators, and other products.
5. New DaZheng Property Group: Plans to acquire not less than 51% stake in Jia Xin Li Heng Facility Management (Shanghai) Co., Ltd., stock trading halted
New DaZheng Property Group announced that the company is planning to issue shares and pay cash to acquire not less than 51% equity interest in Jia Xin Li Heng Facility Management (Shanghai) Co., Ltd., and raise supporting funds. This transaction is expected to constitute a significant asset restructuring. The company's stock has been suspended from trading since September 15, 2025, and the company expects to disclose the transaction plan within 10 trading days.
6. Kexing Biopharm: Shareholders' inquiry transfer preliminary pricing at 30.88 yuan/share, a discount of 28% from today's closing price
Kexing Biopharm announced that based on the subscription inquiry status on September 15, 2025, the preliminary price for this inquiry transfer was determined to be 30.88 yuan per share. A total of 21 institutional investors participated in the quotation and subscription, with a total effective subscription of 10.19 million shares, corresponding to an effective subscription ratio of 1.01 times. The planned transfer shares for this inquiry have been fully subscribed, and the preliminary designated transferees are 21 institutional investors, with a total planned transfer of 10.0628 million shares. Kexing Biopharm's closing price today was 42.81 yuan per share, with an inquiry transfer price discount of 28%.
7. Zotye Automobile: Second-instance ruling requires the company to pay Shanghai Sizhi 29.5 million yuan and overdue interest, which may have a significant impact on the current or future performance
Zotye Automobile announced that it had previously disclosed that the plaintiff Shanghai Sizhi filed a lawsuit against the company in the Jinhua Intermediate People's Court for a dispute over intellectual property rights contracts, with the main litigation request being to request the defendant to pay intellectual property licensing fees and overdue interest. The company counterclaimed to rescind the intellectual property contract signed by both parties. The company recently received the Civil Judgment from the Zhejiang Provincial Higher People's Court, the second-instance ruling maintained the rescission of the intellectual property contract signed by both parties, and simultaneously revoked the content of the first-instance ruling dismissing all claims of Shanghai Sizhi, changing it to a ruling for Zotye Automobile to pay Shanghai Sizhi 29.5 million yuan and overdue interest. This ruling may have a significant impact on the company's current or future performance.
8. Ingenic Semiconductor: Shareholder Beijing Yitang Shengxin reduced holdings by 4.8254 million shares
Ingenic Semiconductor announced that the company's shareholder Beijing Yitang Shengxin Semiconductor Industrial Investment Center (Limited Partnership) reduced its holdings of the company's shares by 4.8254 million shares through centralized bidding from July 18, 2025, to September 12, 2025, with a reduction ratio of 0.999999%. This equity change will not lead to a change in the company's controlling interest or have an impact on the company's ongoing operations.
9. Leader Harmonious Drive Systems: Co-controlling shareholders, the first and second largest shareholders Zuo Jing and Zuo Yuyu have completed a reduction of 2.99% of the company's shares
Leader Harmonious Drive Systems announced that the company recently received a "Notification Letter on the Results of Share Reduction" from Zuo Jing and Zuo Yuyu, detailing the implementation results of the share reduction plan as follows: as of September 15, 2025, Zuo Jing has reduced a total of 2.7451 million shares of the company, accounting for 1.4974% of the total share capital, and Zuo Yuyu has reduced a total of 2.7408 million shares of the company, accounting for 1.4950% of the total share capital. The share reduction plan has been completed.
10. Nanjing Sunlord Electronics Corporation LTD.: Plans to acquire 88.79% equity of IC product distribution company Ligong Technology for 700 million yuan
Nanjing Sunlord Electronics Corporation LTD. announced that the company plans to issue convertible corporate bonds to unspecified objects, with a total fundraising amount not exceeding 1 billion yuan, to be used for the acquisition of Ligong Technology's equity project and supplementary working capital. The company plans to acquire 88.79% of Ligong Technology's equity through its wholly-owned subsidiary, Changying Holdings, for 700 million yuan, to achieve actual control of Ligong Technology. Ligong Technology is mainly engaged in the authorized distribution of MCU chips, driver chips, storage chips, and other types of IC products, representing well-known chip brands such as NXP, ISSI, and 3 PEAK. After the acquisition, the company will achieve actual control of Ligong Technology, integrate the well-known original factory agency qualifications of both parties, gather customer resources, and improve profitability.
Stock Movement Risk Disclosure
1. 20CM limit three days, two boards Nanfang Ventilator: Southern Additive 3D Printing Service Project's fixed asset investment has not yet been finalized
2. 9 days, 8 boards Beijing Capital Development: Recently, the company's stock trading has shown a significant increase in the number of shareholders, with individual institutional shareholders reducing their holdings and clearing positions.
Business Performance
1. Shenzhen Overseas Chinese Town: Contract sales amount in August was 990 million yuan, a 57% decrease year-on-year.
2. China Eastern Airlines Corporation: Passenger traffic in August increased by 8.72% year-on-year.
Repurchase & Increase/Decrease Holdings
1. Guotai Epoint Software: Chairman proposes to repurchase shares worth 30-50 million yuan.
2. Shanghai Orient-Chip Technology: Plans to repurchase company shares in the range of 20-40 million yuan.
3. Qilu Bank Co., Ltd.: Some directors and senior executives plan to increase their holdings of company shares by not less than 3.5 million yuan.
4. Shanghai Pharmaceuticals Holding: Controlling shareholder proposes to increase its H-share holdings by 55-74 million shares through its wholly-owned subsidiary.
5. Zoy Home Furnishing: Chairman Cao Yong plans to reduce holdings of company shares by up to 3%.
6. Fanli Digital Technology: Shareholder Changji Group plans to reduce its holdings of the company by no more than 1%.
Major Deals
1. Lizhong Sitong Light Alloys Group: Received a fixed-point for an expected 5.8 billion yuan aluminum alloy wheel project.
2. Suzhou SLAC Precision Equipment: Signed a 230 million yuan new energy precision structural parts project investment cooperation agreement.
3. Hongrun Construction Group: A bid for a 126 million yuan project.
This article is reprinted from "Tencent Stock Selection," GMTEight editor: Chen Wenfang.
Related Articles

Shareholders of Longxing Technology Group (002442.SZ), Bohai Trust, plan to reduce their shareholding by no more than 1%.

HUANXI MEDIA (01003): Li Ni resigns as non-executive director

Tianshui Huatian Technology (002185.SZ) subsidiary intends to participate in the special investment in a semiconductor chip design company.
Shareholders of Longxing Technology Group (002442.SZ), Bohai Trust, plan to reduce their shareholding by no more than 1%.

HUANXI MEDIA (01003): Li Ni resigns as non-executive director

Tianshui Huatian Technology (002185.SZ) subsidiary intends to participate in the special investment in a semiconductor chip design company.
